While vigorous exercise slows the progression of Parkinson’s disease, the reasons behind it have remained a mystery.
But now scientists at the University of Colorado Anschutz Medical Campus may have an answer.
For the first time in a mouse model of Parkinson’s, researchers have shown that exercise on a running wheel can stop the accumulation of the neuronal protein alpha-synuclein in brain cells.
The researchers said clumps of alpha-synuclein are believed to play a central role in the brain cell death associated with Parkinson’s disease.
The mice in the study, like humans, started to get Parkinson’s symptoms in mid-life. At 12 months of age, running wheels were put in their cages.
“After three months, the running animals showed much better movement and cognitive function compared to control transgenic animals which had locked running wheels,” says researcher Wenbo Zhou, PhD, research associate professor of medicine.
Exercise turns on protective gene
In the running mice, exercise increased brain and muscle expression of a key protective gene called DJ-1. Those rare humans born with a mutation in their DJ-1 gene are guaranteed to get severe Parkinson’s at a relatively young age.
The researchers tested mice that were missing the DJ-1 gene and discovered that their ability to run had severely declined, suggesting that the DJ-1 protein is required for normal movement.
“Our results indicate that exercise may slow the progression of Parkinson’s disease by turning on the protective gene DJ-1 and thereby preventing abnormal protein accumulation in brain,” says co-researcher Curt Freed, MD, professor of medicine and division head of the Division of Clinical Pharmacology and Toxicology.
“Our experiments show that exercise can get to the heart of the problem in Parkinson’s disease. People with Parkinson’s who exercise are likely able to keep their brain cells from dying.”
What is Parkinson’s disease?
Parkinson’s is a disease caused by the death of brain cells that make a critical chemical called dopamine. Without dopamine, voluntary movement is impossible.
Most people with Parkinson’s disease take a drug called L-DOPA to treat their symptoms. The oral drug is converted into dopamine in the brain allowing patients to get up and move.
Source: University of Colorado Anschutz Medical Campus via www.sciencedaily.com
While All4Women endeavours to ensure health articles are based on scientific research, health articles should not be considered as a replacement for professional medical advice. Should you have concerns related to this content, it is advised that you discuss them with your personal healthcare provider.